WallStreetZenWallStreetZen

NASDAQ: REPL
Replimune Group Inc Stock Ownership - Who owns Replimune Group?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Replimune Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sushil PatelChief Executive Officer2024-12-1610,000$12.42
$124.20kSell
Christopher SarchiChief Commercial Officer2024-11-185,207$10.78
$56.13kSell
Konstantinos XynosChief Medical Officer2024-11-187,246$10.78
$78.11kSell
Emily Luisa HillChief Financial Officer2024-08-168,938$10.18
$90.99kSell
Konstantinos XynosChief Medical Officer2024-06-0715,881$7.50
$119.11kSell
Andrew SchwendenmanChief Accounting Officer2024-05-162,298$6.47
$14.87kSell
Konstantinos XynosChief Medical Officer2024-05-166,367$6.47
$41.19kSell
Christopher SarchiChief Commercial Officer2024-05-162,218$6.47
$14.35kSell
Robert CoffinDirector2024-05-1611,464$6.47
$74.17kSell
Colin LoveChief Operating Officer2024-05-1617,615$6.47
$113.97kSell

1 of 2

REPL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REPL insiders and whales buy or sell their stock.

REPL Shareholders

What type of owners hold Replimune Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP14.34%11,045,336$85.16MInstitution
Price T Rowe Associates Inc14.23%10,962,883$84.52MInstitution
Baker Bros Advisors LP13.14%10,116,095$78.00MInsider
Omega Fund IV LP12.25%9,436,760$72.76MInsider
Blackrock Inc7.23%5,566,397$42.92MInstitution
Redmile Group LLC6.37%4,905,527$37.82MInstitution
Forbion Capital Fund III Cooperatief Ua6.13%4,721,449$36.40MInsider
Hugo Alexander Slootweg6.13%4,721,449$36.40MInsider
Fcpm III Services Bv5.16%3,970,668$30.61MInstitution
Vanguard Group Inc4.67%3,595,848$27.72MInstitution

1 of 3

REPL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REPL65.10%34.90%Net Selling
ABUS27.17%72.83%Net SellingNet Selling
TRVI30.28%69.72%Net BuyingNet Buying
ANAB45.45%54.55%Net BuyingNet Buying
KALV57.73%42.27%Net BuyingNet Buying
View Top Biotech Stocks

Replimune Group Stock Ownership FAQ

Who owns Replimune Group?

Replimune Group (NASDAQ: REPL) is owned by 101.13% institutional shareholders, 54.20% Replimune Group insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Replimune Group shareholder, owning 10.12M shares representing 13.14% of the company. Baker Bros Advisors LP's Replimune Group shares are currently valued at $77.19M.

If you're new to stock investing, here's how to buy Replimune Group stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.